For what it is worth I went back and had a look at the Strategy update at the end of 2016 and the reformulation of into powder is part of the Q1 milestones to prepare for the human trials. So IMO that it is underway is a good thing as it is in line with their strategy.
For what it is worth I went back and had a look at the Strategy...
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
17.5¢ |
Change
0.005(2.94%) |
Mkt cap ! $82.69M | |||
| Open | High | Low | Value | Volume |
| 17.5¢ | 17.5¢ | 17.0¢ | $52.47K | 300.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 12 | 567354 | 17.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 18.0¢ | 205056 | 4 |
View Market Depth
| Last trade - 14.27pm 10/09/2024 (20 minute delay) ? |
| PAA (ASX) Chart |